San Francisco, CA – Molecular You, a leader in multi-biomarker analytics and decision support for clinicians, is set to make a significant impact at the upcoming JP Morgan Healthcare Week in San Francisco, from January 7th to 12th. CEO Jim Kean and Chief Scientific Officer Rob Fraser will represent the company at key events, highlighting Molecular You’s groundbreaking AI-powered blood analytics platform.
Event Details:
Biotech Showcase – Digimed
Date: January 8th-10th
Presenter: Jim Kean, CEO, Molecular You
Overview: Jim Kean will present Molecular You’s innovative solutions in the Digimed track of the Biotech Showcase, focusing on the company’s unique approach to predictive risk profiles in health. This session is a must-attend for investors and industry leaders interested in the forefront of health technology.
About Biotech Showcase: This event is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Now in its 16th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings.
RESI-JPM 2024
Date: January 9th
Presenter: Rob Fraser, CSO, Molecular You
Overview: At the RESI conference, Rob Fraser will pitch Molecular You as an innovative company seeking to raise $5 million in seed investment. This event is a prime opportunity for early-stage investors and strategic partners to engage with Molecular You’s cutting-edge technology and investment potential.
About RESI: Connecting startups with global investors across drugs, devices, diagnostics, and digital health, RESI is a key platform for advancing early-stage life science and healthcare innovations.
InnovatorMD – Global Summit 2024
Date – January 10th-13th (Presentation on the 13th)
Presenter: Jim Kean, CEO, Molecular You
Overview: Jim Kean will highlight Molecular You’s role as an innovative force in healthcare at the InnovatorMD Global Summit. The company aims to secure $5 million in seed investment and expand its clinical business leads, bringing its advanced molecular-level testing solution to patients nationwide.
About InnovatorMD: This event is an opportunity for innovators, investors, and clinicians to discover and engage with the future of personalized healthcare.
About Molecular You:
Molecular You is the first and only multi-biomarker analytics platform offering highly accurate predictive risk profiles in over 26 health cares. Leveraging quantitative proteomics and metabolomics with over 800 biomarkers, their AI-driven software delivers unparalleled accuracy in predicting health risks, ranging from 88% for chronic conditions to mid-90% for cognitive disorders.
Leave a Reply